Kiora Pharmaceuticals Inc Cash Flow Reinvestment Rate
Kiora Pharmaceuticals Inc cash flow reinvestment rate. Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Reinvestment Rate of 2.09x as of September 2024, reinvesting $1.92 Million (capex $3.00 plus investments $-1.92 Million) from operating cash flow of $920.06K. Explore KPRX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Kiora Pharmaceuticals Inc (2024–2024)
Cash flow reinvestment rate of Kiora Pharmaceuticals Inc from 2024 to 2024. Historical reinvestment intensity for Kiora Pharmaceuticals Inc across 1 annual periods. Explore capital reinvestment ratio of Kiora Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Kiora Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2024–2024)
Kiora Pharmaceuticals Inc cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Kiora Pharmaceuticals Inc. For the full cash flow conversion analysis, see KPRX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.65x | $22.67 Million | $8.56 Million | $6.26K | — |